NO981078L - Faste blandinger av cyklodekstriner fremstilt via smelteekstrusjon - Google Patents

Faste blandinger av cyklodekstriner fremstilt via smelteekstrusjon

Info

Publication number
NO981078L
NO981078L NO981078A NO981078A NO981078L NO 981078 L NO981078 L NO 981078L NO 981078 A NO981078 A NO 981078A NO 981078 A NO981078 A NO 981078A NO 981078 L NO981078 L NO 981078L
Authority
NO
Norway
Prior art keywords
melt extrusion
prepared via
solid mixtures
via melt
cyclodextrins prepared
Prior art date
Application number
NO981078A
Other languages
English (en)
Other versions
NO981078D0 (no
Inventor
Lieven Elvire Colette Baert
Jozef Peeters
Geert Verreck
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26139823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO981078(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO981078D0 publication Critical patent/NO981078D0/no
Publication of NO981078L publication Critical patent/NO981078L/no

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO981078A 1995-11-23 1998-03-11 Faste blandinger av cyklodekstriner fremstilt via smelteekstrusjon NO981078L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP95203219 1995-11-23
PCT/EP1996/005118 WO1997018839A1 (en) 1995-11-23 1996-11-20 Solid mixtures of cyclodextrins prepared via melt-extrusion
US09/081,808 US6365188B1 (en) 1995-11-23 1998-05-20 Solid mixtures of cyclodextrins prepared via meltextrusion

Publications (2)

Publication Number Publication Date
NO981078D0 NO981078D0 (no) 1998-03-11
NO981078L true NO981078L (no) 1998-05-22

Family

ID=26139823

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981078A NO981078L (no) 1995-11-23 1998-03-11 Faste blandinger av cyklodekstriner fremstilt via smelteekstrusjon

Country Status (16)

Country Link
US (1) US6365188B1 (no)
EP (1) EP0862463A1 (no)
JP (1) JP3310299B2 (no)
CN (1) CN1198655C (no)
AU (1) AU725204B2 (no)
BR (1) BR9611562A (no)
CZ (1) CZ154398A3 (no)
HU (1) HUP9900730A3 (no)
IL (1) IL123654A (no)
NO (1) NO981078L (no)
NZ (1) NZ322907A (no)
PL (1) PL189122B1 (no)
SK (1) SK67298A3 (no)
TR (1) TR199800729T2 (no)
WO (1) WO1997018839A1 (no)
ZA (1) ZA969831B (no)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ322907A (en) * 1995-11-23 1998-12-23 Janssen Pharmaceutica Nv Solid mixtures of cyclodextrins prepared via melt-extrusion
KR19990001564A (ko) * 1997-06-16 1999-01-15 유충식 용해도를 개선한 아졸계 항진균제 및 이를 함유하는 제제
DE59803468D1 (de) 1997-11-28 2002-04-25 Knoll Ag Verfahren zur herstellung von lösungsmittelfreien nicht-kristallinen biologisch aktiven substanzen
US6683100B2 (en) 1999-01-19 2004-01-27 Novartis Ag Organic compounds
US6194181B1 (en) 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
HU230394B1 (hu) 1998-11-10 2016-04-28 Janssen Pharmaceutica N.V. HIV-vírus szaporodását gátló pirimidin-származékok
US6194395B1 (en) 1999-02-25 2001-02-27 Orthro-Mcneil Pharmaceutical, Inc. Cyclodextrin cladribine formulations
DE19911097A1 (de) * 1999-03-12 2000-09-14 Basf Ag Verfahren zur Herstellung von festen cyclodextrinhaltigen Dosierungsformen
BR0009176A (pt) 1999-03-24 2001-12-18 Fmc Corp Partìcula granular, forma de dosagem, métodopara preparar uma partìcula granular, misturaseca, e, formulação granular
SK15772001A3 (sk) 1999-05-04 2002-12-03 Janssen Pharmaceutica N. V. Antifungálne étery
FR2803748A1 (fr) * 2000-01-14 2001-07-20 Ethypharm Lab Prod Ethiques Composition d'itraconazole et procede de preparation
ES2317889T3 (es) 2000-03-01 2009-05-01 Janssen Pharmaceutica Nv Derivados de tiazolilo 2,4-disustituido.
US6835717B2 (en) 2000-03-08 2004-12-28 The Johns Hopkins University School Of Medicine β-cyclodextrin compositions, and use to prevent transmission of sexually transmitted diseases
CA2406562C (en) 2000-05-08 2009-09-15 Janssen Pharmaceutica N.V. Hiv replication inhibiting pyrimidines and triazines
ITRN20000051A1 (it) 2000-12-22 2002-06-22 Ascor Chimici Srl Metodo e apparecchiatura per formare sferule composite contenenti principi attivi del tipo farmaceutico e/o integratori alimentari o cosmeti
GB0113841D0 (en) * 2001-06-07 2001-08-01 Boots Co Plc Therapeutic agents
US7638522B2 (en) 2001-08-13 2009-12-29 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino] benzonitrile
JO3429B1 (ar) 2001-08-13 2019-10-20 Janssen Pharmaceutica Nv مشتقات برميدينات مثبطة فيروس الايدز
AU2002324045C1 (en) 2001-08-13 2008-05-29 Janssen Pharmaceutica N.V. 2-amino-4,5-trisubstituted thiazolyl derivatives and their use against autoimmune diseases
US8101629B2 (en) 2001-08-13 2012-01-24 Janssen Pharmaceutica N.V. Salt of 4-[[4-[[4-(2-cyanoethenyl)-2,6-dimethylphenyl]amino]-2-pyrimidinyl]amino]benzonitrile
BR0307599A (pt) 2002-03-13 2005-02-01 Janssen Pharmaceutica Nv Derivados de sulfonilamino como inibidores de histona deacetilase
IL164007A0 (en) 2002-03-13 2005-12-18 Janssen Pharmaceutica Nv New inhibitors of histone deacetylase
CN102702111B (zh) 2002-08-09 2014-12-17 詹森药业有限公司 制备4-[[4-[[4-(2-氰基乙烯基)-2,6-二甲基苯基]氨基]-2-嘧啶基]氨基]苄腈的方法
ES2311146T3 (es) 2003-02-07 2009-02-01 Janssen Pharmaceutica Nv 1,2,4-triazinas que inhiben el vih.
BRPI0407329A (pt) 2003-02-07 2006-01-10 Janssen Pharmaceutica Nv Derivados de pirimidina para a prevenção de infecção de hiv
CL2004000306A1 (es) 2003-02-20 2005-04-08 Tibotec Pharm Ltd Compuestos derivados de pirimidina sustituidas con indano; proceso para su preparacion; composicion farmaceutica que lo comprende; combinacion farmaceutica; y su uso para el tratamiento o profilaxis de una enfermedad infecciosa.
CN101912615B (zh) * 2003-03-28 2013-03-27 阿莱斯贸易有限公司 用于改善的经口和透粘膜输送的克拉屈滨制剂
ATE476177T1 (de) * 2003-03-28 2010-08-15 Ares Trading Sa Orale zubereitungen enthaltend cladribin
ATE500254T1 (de) 2003-09-25 2011-03-15 Janssen Pharmaceutica Nv Die replikation von hiv hemmende purinderivate
US20050118265A1 (en) * 2003-11-28 2005-06-02 Anandi Krishnan Antifungal oral dosage forms and the methods for preparation
MX2007001120A (es) 2004-07-28 2007-03-15 Janssen Pharmaceutica Nv Derivados de indolil alquil sustituidos como nuevos inhibidores de la histona desacetilasa.
US7923554B2 (en) 2004-08-10 2011-04-12 Janssen Pharmaceutica N.V. HIV inhibiting 1,2,4-triazin-6-one derivatives
AU2005288866B2 (en) 2004-09-30 2012-07-26 Janssen Sciences Ireland Uc HIV inhibiting 5-substituted pyrimidines
CA2577467C (en) 2004-09-30 2013-05-28 Tibotec Pharmaceuticals Ltd. Hiv inhibiting 5-heterocyclyl pyrimidines
US8153640B2 (en) 2004-10-29 2012-04-10 Tibotec Pharmaceuticals Ltd. HIV inhibiting bicyclic pyrimdine derivatives
WO2006079656A1 (en) 2005-01-27 2006-08-03 Tibotec Pharmaceuticals Ltd. Hiv inhibiting 2-( 4-cyanophenylamino) pyrimidine derivatives
DK1858861T3 (da) 2005-03-04 2010-11-08 Tibotec Pharm Ltd HIV-inhiberende 2-(4-cyanophenyl)-6-hydroxylaminopyrimidiner
DK1912626T3 (en) * 2005-08-08 2016-08-01 Abbvie Deutschland Dosage forms with improved bioavailability
WO2007047253A2 (en) * 2005-10-11 2007-04-26 Eastman Chemical Company Pharmaceutical formulations of cyclodextrins and antifungal azole compounds
US8114876B2 (en) 2006-01-19 2012-02-14 Janssen Pharmaceutica N.V. Pyridine and pyrimidine derivatives as inhibitors of histone deacetylase
EP1832281A1 (en) * 2006-03-10 2007-09-12 Abbott GmbH & Co. KG Process for producing a solid dispersion of an active ingredient
BRPI0709266B8 (pt) 2006-03-30 2021-05-25 Janssen R & D Ireland 5-(hidroximetileno e aminometileno) pirimidinas substituídas e composição farmacêutica que as compreende
JP5078986B2 (ja) 2006-03-30 2012-11-21 テイボテク・フアーマシユーチカルズ Ｈｉｖを阻害する５−アミド置換されたピリミジン
EP2781510B1 (en) 2006-12-29 2016-12-14 Janssen Sciences Ireland UC Hiv inhibiting 5,6-substituted pyrimidines
BRPI0720858B8 (pt) 2006-12-29 2021-05-25 Janssen R & D Ireland pirimidinas 6-substituídas inibidoras de hiv e composição farmacêutica que as compreende
EP2280681A1 (en) * 2008-04-30 2011-02-09 Novartis AG Continuous process for making pharmaceutical compositions
WO2010128359A1 (en) 2009-05-07 2010-11-11 Gea Pharma Systems Limited Tablet production module and method for continuous production of tablets
US20120148678A1 (en) 2010-12-08 2012-06-14 Advanced Technologies And Regenerative Medicine, Llc. Sustained release of poorly water soluble active compounds
US10532102B2 (en) 2016-08-19 2020-01-14 Foresee Pharmaceuticals Co., Ltd. Pharmaceutical composition and methods of uses
CN107441504A (zh) * 2017-09-06 2017-12-08 广州中医药大学 番茄红素包合物及其制备方法及番茄红素包合物片剂、胶囊和颗粒
CN110898015A (zh) * 2019-12-31 2020-03-24 上海汉维生物医药科技有限公司 一种伊曲康唑制剂的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61152765A (ja) * 1984-12-27 1986-07-11 Nippon Ekishiyou Kk シクロデキストリン類で包接された化合物を含有した合成樹脂製品及びその製造方法
US5009900A (en) * 1989-10-02 1991-04-23 Nabisco Brands, Inc. Glassy matrices containing volatile and/or labile components, and processes for preparation and use thereof
KR100291361B1 (ko) * 1992-10-14 2001-09-17 니뽄 신야쿠 가부시키가이샤 결정상태의전이방법
AU5376994A (en) * 1992-11-10 1994-06-08 Nippon Shinyaku Co. Ltd. Enclosure compound manufacturing method
FR2705677B1 (fr) * 1993-05-28 1995-08-11 Roquette Freres Micro-granules obtenus par extrusion-sphéronisation contenant une cyclodextrine.
NZ322907A (en) * 1995-11-23 1998-12-23 Janssen Pharmaceutica Nv Solid mixtures of cyclodextrins prepared via melt-extrusion
KR100331529B1 (ko) 1999-06-16 2002-04-06 민경윤 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법

Also Published As

Publication number Publication date
BR9611562A (pt) 1999-03-02
WO1997018839A1 (en) 1997-05-29
HUP9900730A3 (en) 2001-04-28
NZ322907A (en) 1998-12-23
TR199800729T2 (xx) 1998-07-21
EP0862463A1 (en) 1998-09-09
PL189122B1 (pl) 2005-06-30
ZA969831B (en) 1998-05-22
SK67298A3 (en) 1998-11-04
IL123654A (en) 2001-08-08
CZ154398A3 (cs) 1998-08-12
AU725204B2 (en) 2000-10-05
IL123654A0 (en) 1998-10-30
JPH11501050A (ja) 1999-01-26
NO981078D0 (no) 1998-03-11
AU7694396A (en) 1997-06-11
PL326161A1 (en) 1998-08-31
US6365188B1 (en) 2002-04-02
JP3310299B2 (ja) 2002-08-05
CN1198655C (zh) 2005-04-27
CN1200677A (zh) 1998-12-02
HUP9900730A2 (hu) 1999-07-28

Similar Documents

Publication Publication Date Title
NO981078L (no) Faste blandinger av cyklodekstriner fremstilt via smelteekstrusjon
HUP9903384A3 (en) Solid medicaments obtained by extrusion of an isomalt-containing polymer-active substance melt
BR9606733A (pt) Produção de artigos extrudados
DE69621410D1 (de) Stabilisierte thermoplastische Polymerzusammensetzung
PT918892E (pt) Fabrico de artigos extrudidos
NO962603D0 (no) Stabilisert PVC-blanding for fremstilling av formlegemer
NO964685D0 (no) Isomering av equilin
FI956030A0 (fi) Anordning foer extrudering av plastroer
NO962371L (no) Stabilisering av polymerer
KR970000923U (ko) 차량의 백글라스 몰딩구조
KR970039894U (ko) 도어의 플라스틱 문틀
KR970012581U (ko) 차량의 모울딩구조
KR960028572U (ko) 도어섀시의 몰딩재 취부구조
KR970021520U (ko) 자동차 도어 프레임의 몰딩 결합구조
KR970038313U (ko) 화물 자동차의 리어 스텝 구조
KR970005608U (ko) 화물자동차의 후부도어 구조
NO951859D0 (no) Utforming av tunnelåpning
FI950412A0 (fi) Foerfarande och anordning foer effektivisering av en soenderslagningsanordning funktion
FI973297A (fi) Polyhydroksialkanoaatin lateksi
KR970001253U (ko) 버스의 모울딩 인너
KR970029337U (ko) 차량용 도어의 밀폐구조
KR960033922U (ko) 도어 몰딩의 앤드 캡 구조
FI955217A0 (fi) Foerfarande foer framstaellning av braensle av slam
KR970032447U (ko) 화물자동차의 적재함 구조
KR970015063U (ko) 알람기능을 가진 카 오디오

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application